Front Desk: 469-391-0070
Ribociclib Cancer Treatment: Uses, Dosage, and Effectiveness
Summary of Key Points
Ribociclib is a prescription medication used to treat certain types of breast cancer, specifically hormone receptor-positive and HER2-negative breast cancers. It works by inhibiting proteins that promote the growth of cancer cells. Ribociclib is typically prescribed in combination with other therapies, such as hormone treatments. It is essential to follow your healthcare provider’s instructions carefully and consult your doctor before making any changes to your dosage.
Names of Medication
US Brand Name: Kisqali
Generic Name: Ribociclib
The generic name refers to the chemical name of the active ingredient in the medication. It is listed in parentheses after the brand name.
Pharmacologic Category
Cyclin-dependent kinase (CDK) 4/6 inhibitor
Ribociclib Dosage for Breast Cancer Treatment
Ribociclib is used to treat various types of breast cancer in adults. The dosing schedule may vary depending on the specific type of breast cancer being treated. Always consult your doctor before adjusting your dose. If you need to speak to a healthcare provider, you can schedule a telemedicine appointment with one of our doctors right away.
Breast Cancer (Hormone Receptor-Positive, HER2-Negative, Metastatic)
Recommended Dose: 600 mg orally once daily for 21 consecutive days, followed by 7 days off treatment. This cycle repeats every 28 days.
Early-Stage Breast Cancer
Recommended Dose: 600 mg orally once daily for 21 consecutive days, followed by 7 days off treatment, in combination with endocrine therapy.
Triple-Negative Breast Cancer
Recommended Dose: Ribociclib is not typically used for triple-negative breast cancer. Consult your doctor for alternative treatment options.
HER2-Positive Breast Cancer
Recommended Dose: Ribociclib is not indicated for HER2-positive breast cancer. Please discuss other treatment options with your healthcare provider.
Lobular Breast Cancer
Recommended Dose: 600 mg orally once daily for 21 consecutive days, followed by 7 days off treatment, in combination with other therapies.
Invasive Breast Cancer
Recommended Dose: 600 mg orally once daily for 21 consecutive days, followed by 7 days off treatment, in combination with endocrine therapy.
Estrogen Receptor-Positive Breast Cancer
Recommended Dose: 600 mg orally once daily for 21 consecutive days, followed by 7 days off treatment, in combination with hormone therapy.
Dosage Forms and Strengths
Tablets: 200 mg
Administration Instructions for Ribociclib
Ribociclib should be taken by mouth once daily, ideally at the same time each day. It can be taken with or without food. Swallow the tablets whole; do not crush, chew, or split them. If you miss a dose or vomit after taking it, do not take an extra dose. Simply continue with your next scheduled dose. Always follow your healthcare provider’s instructions carefully.
Contraindications for Ribociclib
A contraindication is a specific condition or situation where a particular medication should not be used because it may cause harm. If you have any of the following conditions, taking Ribociclib may not be safe for you. Always discuss your medical history with your healthcare provider before starting any new medication.
Allergy to Ribociclib or its components: If you have a known allergy to Ribociclib or any of its ingredients, taking the medication could cause a severe allergic reaction, which may include symptoms like rash, difficulty breathing, or swelling.
Heart rhythm disorders (QT prolongation): Ribociclib can prolong the QT interval, a measure of the heart’s electrical activity. If you already have a heart rhythm disorder, taking Ribociclib could increase your risk of dangerous arrhythmias.
Severe liver disease: Ribociclib is processed by the liver. If you have severe liver disease, your body may not be able to break down the medication properly, leading to increased side effects or toxicity.
Electrolyte imbalances: Low levels of potassium, magnesium, or calcium in your blood can increase the risk of heart problems when taking Ribociclib. Your healthcare provider will likely check your electrolyte levels before starting treatment.
Drug-to-Drug Interactions with Ribociclib
Ribociclib can interact with other medications, which may affect how well it works or increase the risk of side effects. Be sure to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, supplements, and herbal products. Below are some medications that may interact with Ribociclib:
- Ketoconazole (Nizoral): This antifungal medication can increase Ribociclib levels in your blood, raising the risk of side effects.
- Rifampin (Rifadin): This antibiotic can decrease the effectiveness of Ribociclib by lowering its levels in your blood.
- Carbamazepine (Tegretol): Used to treat seizures, this medication can reduce Ribociclib’s effectiveness.
- St. John’s Wort: This herbal supplement, often used for depression, can lower Ribociclib levels in your body, making it less effective.
- Amiodarone (Pacerone): This heart medication can increase the risk of QT prolongation when taken with Ribociclib, leading to potential heart rhythm issues.
Ribociclib in Pregnancy
Is it safe to take Ribociclib when pregnant?
No, Ribociclib is not considered safe during pregnancy. It can harm an unborn baby by disrupting cell growth and division, which are crucial during fetal development. If you are pregnant or planning to become pregnant, it’s important to discuss alternative treatments with your healthcare provider. Additionally, you should use effective contraception while taking Ribociclib and continue doing so for at least three weeks after your last dose.
Ribociclib while Breastfeeding
Is it safe to take Ribociclib while breastfeeding?
Breastfeeding while on Ribociclib is not recommended. The medication may pass into breast milk and could potentially harm a nursing infant. If you are currently breastfeeding or planning to breastfeed, consult your healthcare provider to discuss the risks. Together, you can decide whether to discontinue breastfeeding or explore alternative treatments.
Estimated Cost of Ribociclib
The cost of a 30-day supply of Ribociclib (typically 200 mg tablets) without insurance can vary. With a GoodRx coupon, the price for a 30-day supply is approximately $13,000 to $14,000. Prices may differ based on your location and pharmacy, so it’s a good idea to check with your pharmacy or use a discount card to help reduce costs.
Possible Alternatives to Ribociclib
If Ribociclib is not suitable for you, there are other treatment options and lifestyle changes that may help manage your condition. It’s essential to discuss these alternatives with your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to explore these options further.
Breast Cancer Treatment Alternatives
Breast cancer: Alternatives may include other targeted therapies such as Palbociclib (Ibrance) or Abemaciclib (Verzenio), chemotherapy, or hormone therapy, depending on the type and stage of your cancer.
Hormone Receptor-Positive Breast Cancer
Hormone receptor-positive breast cancer: Hormonal therapies like Tamoxifen or Aromatase inhibitors (e.g., Letrozole, Anastrozole) may be effective alternatives.
Metastatic Breast Cancer
Metastatic breast cancer: Treatment options may include chemotherapy, immunotherapy, or other targeted therapies such as Everolimus (Afinitor) or Fulvestrant (Faslodex).
Early-Stage Breast Cancer
Early-stage breast cancer: Common treatments include surgery, radiation therapy, and hormonal therapy. Additionally, lifestyle changes such as maintaining a healthy weight and engaging in regular physical activity may help reduce the risk of recurrence.
Triple-Negative Breast Cancer
Triple-negative breast cancer: Chemotherapy remains the standard treatment, but newer options like immunotherapy (e.g., Pembrolizumab) are being explored.
HER2-Positive Breast Cancer
HER2-positive breast cancer: Targeted therapies such as Trastuzumab (Herceptin) or Pertuzumab (Perjeta) may be used in combination with chemotherapy.
Lobular Breast Cancer
Lobular breast cancer: Treatment options are similar to other types of breast cancer and may include surgery, radiation, hormone therapy, and chemotherapy.
Invasive Breast Cancer
Invasive breast cancer: Common treatments include surgery, radiation, chemotherapy, and targeted therapies. Your healthcare provider will help determine the best approach based on your specific cancer type.
Estrogen Receptor-Positive Breast Cancer
Estrogen receptor-positive breast cancer: Hormonal therapies such as Tamoxifen or Aromatase inhibitors are often used to block estrogen’s effects on cancer cells.
Recent Updates on Ribociclib Research
Recent studies have shown promising results for Ribociclib when used in combination with other therapies. For instance, research indicates that Ribociclib, when paired with endocrine therapy, can significantly improve overall survival in patients with hormone receptor-positive, HER2-negative advanced breast cancer. Ongoing clinical trials are also investigating its potential use in earlier stages of breast cancer and in combination with immunotherapies.
As research continues, new findings may expand Ribociclib’s application to other types of breast cancer or enhance its effectiveness in current treatment protocols. Be sure to consult your healthcare provider or schedule a telemedicine appointment to discuss the latest treatment options and how they may apply to your specific case.
